Novel CAR-T Start-Up Mnemo Bags €75m Series A Financing
Will Fund Cell Therapy Development Using Novel Target Identification Engine
Executive Summary
Mnemo Therapeutics’ promise in chimeric antigen receptor (CAR) T-cell therapy technologies allowed it to raise €75m in a series A financing round and the French biotech’s CEO tells Scrip he aims to raise yet more money in coming months to fund its development plans.